These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 17889691)
1. Iontophoresis significantly increases the trans-dentinal delivery of osteoprotegerin, alendronate, and calcitonin. Kitchens JA; Schwartz SA; Schindler WG; Hargreaves KM J Endod; 2007 Oct; 33(10):1208-11. PubMed ID: 17889691 [TBL] [Abstract][Full Text] [Related]
2. Calcitonin, sodium alendronate and high intensity laser in the treatment of traumatized teeth: a preliminary study. Bello-Silva MS; Lage-Marques JL; Marotti J; de Paula Eduardo C; Apel C; Gutknecht N Lasers Med Sci; 2010 May; 25(3):331-7. PubMed ID: 19011951 [TBL] [Abstract][Full Text] [Related]
3. Permeability characteristics of bovine and human dentin under different pretreatment conditions. Schmalz G; Hiller KA; Nunez LJ; Stoll J; Weis K J Endod; 2001 Jan; 27(1):23-30. PubMed ID: 11487159 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic delivery of calcitonin to inhibit external inflammatory root resorption. I. Diffusion kinetics of calcitonin through the dental root. Wiebkin OW; Cardaci SC; Heithersay GS; Pierce AM Endod Dent Traumatol; 1996 Dec; 12(6):265-71. PubMed ID: 9206373 [TBL] [Abstract][Full Text] [Related]
6. Short-term iontophoretic and post-iontophoretic transport of model penetrants across excised human epidermis. Akomeah FK; Martin GP; Brown MB Int J Pharm; 2009 Feb; 367(1-2):162-8. PubMed ID: 18950696 [TBL] [Abstract][Full Text] [Related]
8. Alendronate binds to tooth root surfaces and inhibits progression of feline tooth resorption: a pilot proof-of-concept study. Mohn KL; Jacks TM; Schleim KD; Harvey CE; Miller B; Halley B; Feeney WP; Hill SL; Hickey G J Vet Dent; 2009; 26(2):74-81. PubMed ID: 19718970 [TBL] [Abstract][Full Text] [Related]
9. Effect of root canal irrigants on cervical dentine permeability to hydrogen peroxide. Surapipongpuntr P; Duangcharee W; Kwangsamai S; Ekka A Int Endod J; 2008 Oct; 41(10):821-7. PubMed ID: 18699786 [TBL] [Abstract][Full Text] [Related]
10. In vivo iontophoretic delivery of salmon calcitonin across microporated skin. Vemulapalli V; Bai Y; Kalluri H; Herwadkar A; Kim H; Davis SP; Friden PM; Banga AK J Pharm Sci; 2012 Aug; 101(8):2861-9. PubMed ID: 22644951 [TBL] [Abstract][Full Text] [Related]
11. The effects of systemic alendronate with or without intraalveolar collagen sponges on postextractive bone resorption: a single masked randomized clinical trial. Graziani F; Rosini S; Cei S; La Ferla F; Gabriele M J Craniofac Surg; 2008 Jul; 19(4):1061-6. PubMed ID: 18650733 [TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of different strengths of electrical current in the management of dentinal hypersensitivity. Sandhu SP; Sharma RL; Bharti V Indian J Dent Res; 2010; 21(2):207-12. PubMed ID: 20657089 [TBL] [Abstract][Full Text] [Related]
13. Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss. Choi HJ; Im JA; Kim SH Maturitas; 2008 Jun; 60(2):170-6. PubMed ID: 18572334 [TBL] [Abstract][Full Text] [Related]
14. Facilitation of iontophoretic drug delivery through intact and caries-affected dentine. Puapichartdumrong P; Ikeda H; Suda H Int Endod J; 2003 Oct; 36(10):674-81. PubMed ID: 14511224 [TBL] [Abstract][Full Text] [Related]
15. In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin. Chaturvedula A; Joshi DP; Anderson C; Morris RL; Sembrowich WL; Banga AK Int J Pharm; 2005 Jun; 297(1-2):190-6. PubMed ID: 15907605 [TBL] [Abstract][Full Text] [Related]
16. The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men. Guven Z; Karadag-Saygi E; Unlu-Ozkan F; Akyuz G Aging Male; 2007 Dec; 10(4):197-201. PubMed ID: 18033629 [TBL] [Abstract][Full Text] [Related]
17. Long-term effects of local pretreatment with alendronate on healing of replanted rat teeth. Komatsu K; Shimada A; Shibata T; Shimoda S; Oida S; Kawasaki K; Nifuji A J Periodontal Res; 2008 Apr; 43(2):194-200. PubMed ID: 18302622 [TBL] [Abstract][Full Text] [Related]
20. Calcitonin may be a useful therapeutic agent for osteoclastogenesis syndromes involving premature eruption of the tooth. Qin H; Yang FS Med Hypotheses; 2008; 70(5):1048-50. PubMed ID: 18023993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]